While semaglutide is not proven to extend lifespan or reverse aging, the study provides early clinical evidence that GLP-1 receptor agonists may influence biological pathways involved in aging and age-related diseases
The study included over 3,000 participants and showed that semaglutide not only improved glycemic control but also had beneficial effects on blood pressure
There is no over-the-counter (OTC) medication that directly mimics the effects of semaglutide
Documentation of optic disc appearance, retinal vascular changes, and nerve fiber layer thickness provides essential data for identifying progressive pathology
Bigini P, Larini S, Pasquali C, et al
Common starting points range from lower doses, with adjustments continuing until you reach your maintenance dose